SCLX Scilex Holding Company

3.960USD+3.66%Mkt Cap: 27.86M $P/E: —

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…

Key Statistics

Company
Market Cap27.86M USD
Enterprise Value131.80M USD
Revenue (TTM)31.61M USD
Gross Profit19.65M USD
Net Income (TTM)-358.73M USD
Revenue/Share3.64 USD
Last Price3.960 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)5.56
PEG—
EV/EBITDA-0.47
EV/Revenue4.17
P/S0.90
P/B-0.09
EPS (TTM)-49.70
EPS (Forward)0.73
52W Range
2.6157% of range21.34
52W High21.34 USD
52W Low2.615 USD
Profitability
Gross Margin64.97%
Oper. Margin-385.02%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth-22.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M USD
CapEx (TTM)733.00K USD
FCF Margin-27.98%
FCF Yield-31.74%
Net Debt105.40M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.07
Quick Ratio0.05
Book Value/Sh-43.83 USD
Cash/Share0.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1606:1000
Split DateJun 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.69M
Insiders11.67%
Institutions8.51%
Short Interest
Short Ratio4.3d
Short % Float3.19%
Short % Out.2.51%
Shares Short176.71K
Short (prev mo.)152.59K
Technical
SMA 505.721 (-30.8%)
SMA 2005.881 (-32.7%)
Beta1.72
S&P 52W Chg14.58%
Avg Vol (30d)38.71K
Avg Vol (10d)34.48K
Technical Indicators
RSI (14)26.4
MACD-0.5245
MACD Signal-0.4729
MACD Hist.-0.0516
BB Upper5.789 USD
BB Middle4.814 USD
BB Lower3.839 USD
BB Width40.52%
ATR (14)0.3860 USD
Vol Ratio (20d)1.74x